Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Niesler

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Toxins|October 26, 2022
Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478Hossein Panjideh, Nicole Niesler, Alexander Weng, et al.
Toxins|July 25, 2022
Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861Hossein Panjideh, Nicole Niesler, Alexander Weng, et al.
Protein Expression and Purification|July 19, 2020
Generation of a soluble and stable apoptin-EGF fusion protein, a targeted viral protein applicable for tumor therapyNicole Niesler, Janine Arndt, Kim Silberreis, et al.
Biomacromolecules|August 29, 2019
Sulfated Dendritic Polyglycerol Is a Potent Complement InhibitorKim Silberreis, Nicole Niesler, Nadine Rades, et al.
BMC Cancer|February 15, 2017
Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapyJessica Pahle, Lutz Menzel, Nicole Niesler, et al.
Biomedicines|May 25, 2017
Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor TherapiesHendrik Fuchs, Nicole Niesler, Alexandra Trautner, et al.
BMC Biotechnology|April 29, 2024
A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861Finn J Schulze, Mazdak Asadian-Birjand, Michael Pradela, et al.
Planta Medica|July 9, 2016
Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-ImmunotoxinRoger Gilabert-Oriol, Mayank Thakur, Katy Haussmann, et al.
Engineering in Life Sciences|March 19, 2025
Recombinant Expression of a Ready-to-Use EGF Variant Equipped With a Single Conjugation Site for Click-ChemistryMelanie Krass, Meike Kolster, José Ignacio Valenzuela, et al.
Biochemical Pharmacology|August 9, 2015
Combinatorial approach to increase efficacy of Cetuximab, Panitumumab and Trastuzumab by dianthin conjugation and co-application of SO1861Roger Gilabert-Oriol, Alexander Weng, Alexandra Trautner, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Toxins|October 26, 2022
Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478Hossein Panjideh, Nicole Niesler, Alexander Weng, et al.
Toxins|July 25, 2022
Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861Hossein Panjideh, Nicole Niesler, Alexander Weng, et al.
Protein Expression and Purification|July 19, 2020
Generation of a soluble and stable apoptin-EGF fusion protein, a targeted viral protein applicable for tumor therapyNicole Niesler, Janine Arndt, Kim Silberreis, et al.
Biomacromolecules|August 29, 2019
Sulfated Dendritic Polyglycerol Is a Potent Complement InhibitorKim Silberreis, Nicole Niesler, Nadine Rades, et al.
BMC Cancer|February 15, 2017
Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapyJessica Pahle, Lutz Menzel, Nicole Niesler, et al.
Biomedicines|May 25, 2017
Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor TherapiesHendrik Fuchs, Nicole Niesler, Alexandra Trautner, et al.
BMC Biotechnology|April 29, 2024
A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861Finn J Schulze, Mazdak Asadian-Birjand, Michael Pradela, et al.
Planta Medica|July 9, 2016
Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-ImmunotoxinRoger Gilabert-Oriol, Mayank Thakur, Katy Haussmann, et al.
Engineering in Life Sciences|March 19, 2025
Recombinant Expression of a Ready-to-Use EGF Variant Equipped With a Single Conjugation Site for Click-ChemistryMelanie Krass, Meike Kolster, José Ignacio Valenzuela, et al.
Biochemical Pharmacology|August 9, 2015
Combinatorial approach to increase efficacy of Cetuximab, Panitumumab and Trastuzumab by dianthin conjugation and co-application of SO1861Roger Gilabert-Oriol, Alexander Weng, Alexandra Trautner, et al.
Pageof 1